Results 71 to 80 of about 102,342,057 (307)
Additional file 1 of On clinical trial fragility due to patients lost to follow up
Additional file 1 Appendix: On Clinical Trial Fragility Due to Patients Lost to Follow ...
Martin T. Wells (8156139) +4 more
core +1 more source
Ligand‐dependent transcriptional heterogeneity in cell cycle gene expression delays G1/S entry
EGF and HRG induce distinct G1/S progression programs in ErbB2‐amplified BT474 breast cancer cells. Despite activating the potent ErbB2–ErbB3 heterodimer, HRG does not accelerate cell‐cycle entry. Instead, EGF promotes earlier restriction‐point passage via ERK–FOS signaling, whereas HRG activates the AKT–MYC axis, driving transcriptional heterogeneity ...
Ririn Rahmala Febri +5 more
wiley +1 more source
How do genomes gain new functional parts? In eukaryotes, which tend to evolve under weak selection, much of the genome is junk. Palazzo and Qiu borrow the logic of Markov chains to show how non‐functional DNA becomes functional through the appearance of intermediate states, which arise due to epistasis, buffering, and biochemical messiness, allowing ...
Alexander F. Palazzo, Yi Qiu
wiley +1 more source
Determinants of lost to follow-up (N = 15,750)*.
Determinants of lost to follow-up (N = 15,750)*.
Ute Sunderbrink (5435330) +7 more
core +1 more source
Heterodimeric amino acid transporters consist of SLC7 and SLC3 family proteins arranged in a conserved structural organization. They regulate nutrient transport across cell membranes, supporting essential cellular functions. These transporters also contribute to xenobiotic/drug uptake and distribution.
Mariafrancesca Scalise +5 more
wiley +1 more source
Selam Fisiha Kassa,1 Workie Zemene Worku,2 Kendalem Asmare Atalell,1 Chilot Desta Agegnehu3 1Department of Pediatrics and Child Health Nursing, School of Nursing, College of Medicine and Health Science, University of Gondar, Gondar, Ethiopia; 2Department
Fisiha Kassa S +3 more
doaj
A context‐dependent modulatory role for eIF6 in acquired resistance to vemurafenib in melanoma
Acquired resistance to vemurafenib upregulates the translation factor eIF6 in melanoma cells. Silencing eIF6 in resistant cells reduces proliferation and partially restores drug sensitivity, whereas its overexpression increases sensitivity across melanoma lines regardless of BRAF status, via modulation of mTOR, S6K, and MAPK signaling.
George Kyriakopoulos +9 more
wiley +1 more source
Cumulative hazard estimate for being lost to follow up.
Cumulative hazard estimate for being lost to follow up.
Eric Goemaere (129370) +9 more
core +1 more source
Data on attrition due to mortality or loss to follow-up (LTFU) from antiretroviral therapy (ART) eligibility to ART initiation of HIV-infected children are scarce.
Gerardo Alvarez-Uria +3 more
doaj +1 more source
Abstract Many physician civic engagement efforts have effectively and appropriately focused on improving physician voter registration and turnout. As we see improvement in these areas for physicians, it is critical not to lose sight of the importance of continued civic engagement, even between elections. Just as we would not discharge
openaire +2 more sources

